✦ LIBER ✦

756 Two Dose-Equivalent, 21-Days, Subcutaneous (S.C.), Glucagon-Like Peptide 2 (GLP-2) Dosing Regimens, 1.0 Mg Continuously Versus 0.33 Mg Three Time Daily (tid), in the Treatment of Short Bowel Syndrome (SBS) Patients

✍ Scribed by Palle B. Jeppesen; Ida B. Gottschalck; Jens J. Holst; Per B. Mortensen; Bolette Hartmann

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P093 TWO DOSE-EQUIVALENT, 21-DAYS, SUBCU

✍ P.B. Jeppesen; I.B. Gottschalck; J.J. Holst; B. Hartman; P.B. Mortensen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

M1824a Two Dose-Equivalent, 56-Days, Sub

✍ Jeppesen, Palle B.; Gottschalck, Ida B.; Holst, Jens J.; Mortensen, Per B. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 137 KB